GSK
785 hedge funds and large institutions have $9.34B invested in GSK in 2017 Q1 according to their latest regulatory filings, with 84 funds opening new positions, 302 increasing their positions, 266 reducing their positions, and 52 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
785
Holders Change
+24
Holders Change %
+3.15%
% of All Funds
19.57%
Holding in Top 10
11
Holding in Top 10 Change
+4
Holding in Top 10 Change %
+57.14%
% of All Funds
0.27%
New
84
Increased
302
Reduced
266
Closed
52
Calls
$137M
Puts
$84.4M
Net Calls
+$52.5M
Net Calls Change
+$36.1M
Top Buyers
Top Sellers
| 1 |
D.E. Shaw & Co
New York
|
$4.96M |
| 2 |
Millennium Management
New York
|
$22.1M |
| 3 |
Grantham, Mayo, Van Otterloo & Co (GMO)
Boston,
Massachusetts
|
$25.7M |
| 4 |
Marshall Wace
London,
United Kingdom
|
$0 |
| 5 |
Two Sigma Investments
New York
|
$86.9M |
